John Maraganore is CEO at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have made 35 open-market trades across 3 companies since 2006, most recently 2026-07-01.
CIK 0001180432
8 open-market purchases totalling $1.9M since 2011, against 27 sales. Across 8 scored buys the stock is up 0.6% at ninety days, and 0.3 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -25.8% | +0.6% | +0.6% |
| Alpha | -20.0% | +0.3% | +0.3% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALNY | SELL | 2021-11-12 | 2021-11-12 | $171.52 | $11.7M | +11.2% | +9.8% | -11.1% |
| ALNY | SELL | 2021-08-13 | 2021-08-16 | $199.77 | $13.5M | +3.4% | -4.2% | -11.4% |
| ALNY | SELL | 2021-05-13 | 2021-05-17 | $130.78 | $8.9M | +3.6% | +24.3% | +45.3% |
| ALNY | SELL | 2021-02-25 | 2021-02-26 | $147.26 | $9.4M | -9.8% | -10.4% | -6.1% |
| ALNY | SELL | 2020-11-19 | 2020-11-20 | $124.23 | $8.6M | +4.9% | +11.5% | +20.2% |
| ALNY | SELL | 2020-08-20 | 2020-08-21 | $136.13 | $9.5M | -4.4% | -4.2% | -9.4% |
| ALNY | SELL | 2020-05-20 | 2020-05-22 | $143.22 | $10.0M | -6.5% | +8.5% | -3.3% |
| ALNY | SELL | 2020-02-20 | 2020-02-21 | $131.85 | $9.2M | -6.6% | -21.1% | +13.0% |
| ALNY | SELL | 2019-10-14 | 2019-10-16 | $79.45 | $7.9M | +9.9% | +12.3% | +44.5% |
| ALNY | SELL | 2019-05-15 | 2019-05-17 | $70.00 | $3.5M | +2.2% | +6.3% | +16.5% |
| AGIO | SELL | 2018-09-11 | 2018-09-13 | $72.23 | $4.0M | +1.9% | -11.8% | -24.7% |
| ALNY | SELL | 2018-07-25 | 2018-07-27 | $105.44 | $10.2M | -10.6% | +8.3% | -25.1% |
| ALNY | SELL | 2017-11-22 | 2017-11-24 | $130.90 | $19.2M | -6.9% | -6.8% | -10.4% |
| ALNY | SELL | 2017-11-15 | 2017-11-17 | $126.86 | $9.4M | +5.6% | -3.6% | -4.4% |
| ALNY | SELL | 2017-11-15 | 2017-11-17 | $126.75 | $13.6M | +5.6% | -3.6% | -4.4% |
| BLUE | SELL | 2017-09-14 | 2017-09-18 | $131.20 | $4.9M | +7.2% | +5.7% | +40.0% |
| BLUE | SELL | 2017-08-02 | 2017-08-28 | $96.18 | $2.2M | +19.3% | +22.9% | +60.3% |
| BLUE | SELL | 2017-03-03 | 2017-03-06 | $85.02 | $2.4M | +11.9% | +1.7% | +10.1% |
| ALNY | SELL | 2016-07-20 | 2016-07-21 | $65.63 | $950K | +8.2% | +16.8% | -43.5% |
| ALNY | SELL | 2016-07-19 | 2016-07-21 | $64.64 | $3.7M | +8.2% | +16.8% | -43.5% |
| ALNY | SELL | 2016-07-19 | 2016-07-21 | $63.81 | $962K | +8.2% | +16.8% | -43.5% |
| ALNY | SELL | 2016-04-20 | 2016-04-21 | $67.52 | $1.0M | -15.2% | -21.8% | -8.3% |
| ALNY | SELL | 2016-04-19 | 2016-04-21 | $67.41 | $3.7M | -15.2% | -21.8% | -8.3% |
| ALNY | SELL | 2016-04-19 | 2016-04-21 | $67.38 | $996K | -15.2% | -21.8% | -8.3% |
| ALNY | SELL | 2016-01-20 | 2016-01-21 | $69.26 | $994K | -11.4% | -14.4% | -8.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.